Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems.

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

The "U.S. Insulin Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" ...

AdvaMed supported changes made from a draft version but still has concerns about the impact on patient access.

Medtronic has announced its financial results for the second quarter of 2026, ending October 24, 2025, demonstrating a revenue increase of 6.6%. Medtronic’s revenue for the quarter reached $9 billion, ...

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

A Massachusetts federal court denied Medtronic’s renewed bid for summary judgment against Anti-Kickback Statute (AKS)–based False Claims Act (FCA) claims. Applying the First Circuit’s recent decision ...

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

Medtronic plc MDT has begun the broad U.S. commercial rollout of the MiniMed 780G system integrated with Abbott’s ABT Instinct sensor, designed exclusively for MiniMed systems. Earlier this year, the ...

The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.